<DOC>
	<DOCNO>NCT01760122</DOCNO>
	<brief_summary>This study aim assess efficacy safety Peginterferon alfa-2b ( 40kD , Y-shape ) , dose 180μg/week , chronic hepatitis B patient , collect sufficient evidence list studied drug .</brief_summary>
	<brief_title>Efficacy Safety Peginterferon Alfa-2b HBeAg Positive Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Age : 18~65 year . Serum HBsAg HBV DNA positive least 6 month . Serum HBsAg HBeAg positive , HBV DNA ≥ 20,000IU/ml screening . 2×ULN≤ ALT ≤10×ULN screening ( ULN=upper limit normal ) . Pregnancy test female patient must negative . All patient effective birth control measure treatment period 6 month treatment . Pregnant lactating woman . Mental disorder physical disability . Interferon treatment history use nucleos ( ) ide analogue chronic hepatitis B treatment within previous 6 month . ANC &lt; 1500/mm3 , PLT &lt; 90,000/mm3 . Coinfection HAV , HIV , HCV , HDV , HEV . Both HBsAg antiHBs positive , HBeAg antiHBe positive screening . ChildPugh ≥ B , evidence hepatitis decompensation ( e.g . : prothrombin time prolong 3 second , TBil &gt; 2ULN , Alb &lt; 35g/L ) . Chronic hepatitis cause reason except hepatitis B. Hepatocarcinoma suffer malignant tumor . Not wellcontrolled endocrine disease ( e.g . : thyroid dysfunction , diabetes mellitus ) Significant function damage major organ ( e.g . : heart , lung , kidney ) . Other Conditions opinion investigator preclude enrollment study ( e.g . : poor compliance ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>peginterferon</keyword>
	<keyword>HBeAg Positive</keyword>
	<keyword>Chronic hepatitis B</keyword>
</DOC>